Cholestyramine Use in Patients With Cirrhosis
Cholestyramine can be used in patients with cirrhosis for cholestasis-associated pruritus because it is a bile-acid sequestrant that acts in the gastrointestinal tract and is generally well tolerated in liver disease. [1] Efficacy data in patients with cirrhosis are limited, but cholestyramine is commonly used as a first-line option for cholestatic pruritus in cirrhosis in clinical reviews. [1]
Side Effects
The most common adverse effects are gastrointestinal effects, particularly constipation. [2] Other gastrointestinal adverse effects include bloating, flatulence, nausea, vomiting, diarrhea, anorexia, heartburn, biliary colic, and indigestion. [3] High doses can contribute to clinically significant vitamin and nutrient malabsorption, particularly vitamin K deficiency, which can increase bleeding risk. [2] Fat-soluble vitamin deficiencies (vitamins A, D, and K) are described in real-world safety data analyses. [4]
Drug-Absorption Interactions Relevant to Cirrhosis
Cholestyramine can bind other medications in the gastrointestinal tract and reduce their absorption. [2] Reported examples of affected medications include warfarin, thyroid hormone preparations, and various other drugs, so spacing doses is often required for safety. [2] Cholestyramine is also associated with interference in the absorption of fat-soluble vitamins, which supports monitoring for deficiency in longer-term therapy. [4]
Practical Considerations for Safety in Cirrhosis
Constipation should be prevented with adequate hydration and fiber strategies when tolerated. [2] Monitoring for bleeding tendency is appropriate when vitamin K deficiency risk is present. [2] Monitoring for fat-soluble vitamin deficiencies is appropriate during prolonged therapy. [4]
Evidence Context for Cirrhosis
Clinical evidence specifically enrolling patients with cirrhosis is limited for cholestyramine, but clinical reviews still support its use for cholestatic pruritus given the favorable tolerability profile in liver disease. [1]
Key Adverse-Event Profile Summary
Constipation is the predominant side effect. [2] Vitamin K deficiency with increased bleeding risk is a major safety concern at higher doses or with prolonged use. [2] Gastrointestinal intolerance and impaired absorption of co-administered medications are the primary practical limitations. [2]